A. Rasidakis

发表

Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.

V. Gorgoulis, A. Karameris, B. Ozanne, 1992, Anticancer research.

Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.

M. Alchanatis, D. Orphanidou, J. Jordanoglou, 1996, Anticancer research.

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

D. Postma, A. Tattersfield, T. Ekström, 2001, The Lancet.

Recurrent respiratory papillomatosis with malignant transformation in a young adult.

M. Gaga, D. Orphanidou, P. Latsi, 1996, Respiratory medicine.

Expression of mdm-2 protein in neoplastic, preneoplastic, and normal bronchial mucosa specimens: comparative study with p53 expression.

G. Papamichalis, D. Orphanidou, A. Sacharidou, 1998, Hybridoma.

Calcific shoulder periarthritis (tendinitis) in adult onset diabetes mellitus: a controlled study.

M. Mavrikakis, D. Kontoyannis, A. Rasidakis, 1989, Annals of the rheumatic diseases.

Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.

M. Gaga, D. Orphanidou, P. Latsi, 1996, Respiratory medicine.

Carcinoembryonic antigen, neuron‐specific enolase and cytokeratin fragment 19 (CYFRA 21‐1) levels in induced sputum of lung cancer patients

P. Bakakos, K. Dimakou, G. Hillas, 2008, Scandinavian journal of clinical and laboratory investigation.

Combined Expression of p53, Bcl-2, and p21WAF-1 Proteins in Lung Cancer and Premalignant Lesions: Association with Clinical Characteristics

C. Roussos, I. Kalomenidis, G. Papamichalis, 2001, Lung.

C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia

T. Vassilakopoulos, P. Bakakos, G. Hillas, 2009, European Respiratory Journal.

CRP and PCT as predictors of survival and septic shock in ventilator-associated pneumonia

T. Vassilakopoulos, P. Bakakos, G. Hillas, 2009 .

Chylothorax and Pseudochylothorax

P. Bakakos, A. Rasidakis, M. Toumbis, 2004 .

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer

S. Marinopoulos, L. Skorda, S. Karatapanis, 2008, Medical oncology.

Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease

P. Bakakos, A. Rasidakis, S. Avgeropoulou, 2009, BMC pulmonary medicine.

Optimal duration of chemotherapy in small cell lung cancer: a randomized study of 4 versus 6 cycles of cisplatin-etoposide.

A. Polyzos, J. Dimitroulis, P. Latsi, 1998, Journal of chemotherapy.

Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.

G. Stratakos, D. Orphanidou, P. Bakakos, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.